trending Market Intelligence /marketintelligence/en/news-insights/trending/quf_aqdsven9lsdknmv5tq2 content esgSubNav
In This List

Tandem Diabetes closes $115M common stock offering

Blog

Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022

Blog

Insight Weekly: Challenges for European banks; Japan's IPO slowdown; carmakers' supply woes


Tandem Diabetes closes $115M common stock offering

Tandem Diabetes Care Inc. closed a common stock offering to raise about $115 million in gross proceeds, the company said in an Aug. 7 press release.

The San Diego-based medical-device maker offered 3,508,770 common shares at $28.50 apiece. In addition, the underwriters fully exercised an option to buy an additional 526,315 shares.

Oppenheimer & Co. Inc. acted as the sole book-running manager, while Robert W. Baird & Co. Inc. acted as a co-manager for the offering.